See today's BioWorld MedTech
To read the full story, subscribe or sign in.

FDA clears Adherium’s Hailie sensor for GSK’s Ellipta inhaler

Aug. 5, 2022
By Tamra Sami
The FDA granted Adherium Ltd. 510(k) clearance for its next-generation Hailie sensor that connects with Glaxosmithkline plc’s Ellipta inhaler to enable monitoring of medication use for asthma and chronic obstructive pulmonary disorder (COPD).
BioWorld MedTech Regulatory Respiratory Digital health Sensors Asia-Pacific Australia 510(k) FDA